LQDA Liquidia Technologies Inc
Company Analysis
Latest News
🔴 Liquidia Technologies is trading 22.7% down after court finds YUTREPIA infringed two patent claims
Liquidia Technologies is trading 22.7% down at $23.39 after a Delaware federal court found YUTREPIA infringed two valid United Therapeutics patent claims...
🔴 Liquidia Technologies is trading 11.1% down in pre-market after court finds YUTREPIA infringed two patent claims
Liquidia Technologies is trading 11.1% down now at $26.90 after a Delaware federal court found YUTREPIA infringed two valid claims of United Therapeutics’...
🔴 Liquidia Technologies is trading 4.63% down in pre-market after court finds YUTREPIA infringes two patent claims
Liquidia Technologies is trading 4.63% down at $28.86 in pre-market on October 1 after a Delaware federal judge found YUTREPIA infringes two valid claims of a...
Court Rules YUTREPIA® Infringes Two Claims of United Therapeutics Patent
Liquidia Corporation announced an adverse ruling in its Hatch-Waxman patent litigation with United Therapeutics. The U.S. District Court for the District of...
Liquidia Plunges Over 48% as Court Finds YUTREPIA Infringed United Therapeutics Patent
A U.S. District Court in Delaware ruled against Liquidia in its patent dispute with United Therapeutics. The court found that Liquidia’s drug, YUTREPIA,...
🔴 Liquidia Technologies is trading 22% down — catalyst remains unclear
Liquidia Technologies is trading at $55.30, down 21.77%, with no confirmed catalyst for the September 30, 2026 decline. - The latest identified company...
🔴 Liquidia Technologies is trading 5% down with no clear company-specific catalyst identified
Liquidia Technologies is trading at $67.14, down -5.01%; no clear company-specific announcement explaining the September 30 decline surfaced in the available...
🔴 Liquidia Technologies is trading 4.3% down as immediate catalyst remains unclear
Liquidia Technologies is trading at $70.53, down 4.27%, with no clear immediate catalyst identified. - No company-specific announcement explaining the...
🟢 Liquidia Technologies is trading 4.1% up — immediate catalyst unclear
Liquidia Technologies is trading 4.12% up at $71.25 on September 28, 2026, with the immediate catalyst unclear. - No confirmed company-specific announcement...
🟢 Liquidia Technologies is trading 4.8% up in pre-market with no confirmed company-specific catalyst
Liquidia Technologies is trading 4.8% higher at $71.71 in pre-market on September 28, with no new company-specific announcement explaining the gain surfaced in...
🔴 Liquidia Technologies is trading 4.05% down today after Zacks Research downgrade over Yutrepia competition
Liquidia Technologies is trading 4.05% down at $68.08 after Zacks Research downgraded it from hold to strong sell on September 24, 2026, citing intensifying...
Liquidia Technologies Downgraded to Strong Sell Amid Yutrepia Competition
Zacks Research downgraded Liquidia Technologies (NASDAQ: LQDA) from hold to strong sell on September 24, 2026. The rating action follows concerns regarding...
🟢 Liquidia Technologies is trading 4.39% up today with catalyst unclear
Liquidia Technologies is trading 4.39% higher at $70.45, with no clear company-specific catalyst identified. - No clear company-specific announcement dated...
Liquidia Technologies Upgraded to Buy, Following 1,842% Revenue Surge
Wall Street Zen upgraded Liquidia Technologies (NASDAQ: LQDA) from Hold to Buy. The broader analyst consensus remains at Hold with an average price target of...
🟢 Liquidia Technologies is trading 4.1% up today with no new company-specific announcement identified
Liquidia Technologies is trading at $68.42, up 4.10%, with no new company-specific announcement dated September 16, 2026 identified. - Latest listed releases:...
Liquidia's YUTREPIA Granted FDA Fast Track Designation for Raynaud's Phenomenon
Liquidia Corporation announced that its product, YUTREPIA® (treprostinil) inhalation powder, has received Fast Track Designation from the U.S. Food and Drug...
🟢 Liquidia Technologies is trading 4.31% up today on broad biotech strength
Liquidia Technologies is trading 4.31% up at $69.80 on broad strength across biotechnology stocks. - Biotech is up 2.75% on patent-related enthusiasm and...
🔴 Liquidia Technologies is trading 4.2% down in pre-market today as Nasdaq Composite falls 0.91%
Liquidia Technologies is trading 4.2% down now at $65.31 after broader markets weakened ahead of U.S. economic data and amid elevated geopolitical and...
Farallon Capital Management Initiates $327M Stake in Liquidia Corp
In a quarterly disclosure filed on August 14, 2026, major investment firm Farallon Capital Management revealed a new significant position in Liquidia...
🔴 Liquidia Technologies is trading 4.1% down today amid biotech pullback after recent rally
Liquidia Technologies is trading 4.1% down at $72.23, with the decline appearing tied mainly to a broader biotech pullback after the sector’s recent rally,...